2024-04-14 21:27:45 ET
Summary
- Zoetis Inc. has seen a significant decline in its stock price, dropping more than 24% since January.
- The decline is partly due to market weakness and the ongoing growth to value rotation, as well as headlines about the potential adverse effects of one of its key drugs.
- Despite the setbacks, Zoetis' core business remains strong, with robust top-line and bottom-line growth expectations, diversified growth opportunities, and a stable dividend.
Introduction
Last year, I started covering Zoetis Inc. ( ZTS ) , the animal health-focused healthcare giant.
My most recent article on this stock was written on January 10, when I went with the title "Animal Kingdom's Ally: Zoetis And Its Path To 10%+ Returns." ...
Read the full article on Seeking Alpha
For further details see:
Despite Lawsuit Risks: Why Zoetis Remains A Compelling Investment